Literature DB >> 23613011

Determination of mental competency, a neurological perspective.

Howard S Kirshner1.   

Abstract

This article discusses the evaluation of the capacity of a person to make informed decisions about financial matters, independent living, and informed consent for medical treatment and research. Determination of capacity is a function for which most physicians have little training. The determination of competency for a general medical patient may be assessed by a combination of a bedside mental status examination such as the MMSE and a questionnaire such as the Aid To Capacity Evaluation (ACE 1999). For patients with focal neurological deficits such as aphasia, further evaluation of specific cognitive and language functions is needed; Alexander (Arch Neurol 45:23-6, 1988) suggested 7 specific functions to be assessed. Finally, in dementing illnesses, evaluation by the MMSE and a questionnaire such as the CCTI, or Capacity to Consent to Treatment Instrument (Marson et al. Arch Neurol 52:949-54, 1995) is needed. Dementia includes several separate syndromes of neurodegenerative disease, and in many of these conditions, focal deficits such as aphasia may necessitate a more thorough neuropsychological evaluation.

Entities:  

Mesh:

Year:  2013        PMID: 23613011     DOI: 10.1007/s11910-013-0356-1

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  26 in total

1.  Classification of primary progressive aphasia and its variants.

Authors:  M L Gorno-Tempini; A E Hillis; S Weintraub; A Kertesz; M Mendez; S F Cappa; J M Ogar; J D Rohrer; S Black; B F Boeve; F Manes; N F Dronkers; R Vandenberghe; K Rascovsky; K Patterson; B L Miller; D S Knopman; J R Hodges; M M Mesulam; M Grossman
Journal:  Neurology       Date:  2011-02-16       Impact factor: 9.910

2.  Neuropsychologic predictors of competency in Alzheimer's disease using a rational reasons legal standard.

Authors:  D C Marson; H A Cody; K K Ingram; L E Harrell
Journal:  Arch Neurol       Date:  1995-10

Review 3.  Does this patient have medical decision-making capacity?

Authors:  Laura L Sessums; Hanna Zembrzuska; Jeffrey L Jackson
Journal:  JAMA       Date:  2011-07-27       Impact factor: 56.272

4.  Competency to consent to medical treatment in cognitively impaired patients with Parkinson's disease.

Authors:  M P Dymek; P Atchison; L Harrell; D C Marson
Journal:  Neurology       Date:  2001-01-09       Impact factor: 9.910

5.  Mild cognitive impairment: to treat or not to treat.

Authors:  Howard S Kirshner
Journal:  Curr Neurol Neurosci Rep       Date:  2005-11       Impact factor: 5.081

6.  Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  R C Petersen; J C Stevens; M Ganguli; E G Tangalos; J L Cummings; S T DeKosky
Journal:  Neurology       Date:  2001-05-08       Impact factor: 9.910

Review 7.  Is informed consent a "yes or no" response? Enhancing the shared decision-making process for persons with aphasia.

Authors:  Joel Stein; Lynne C Brady Wagner
Journal:  Top Stroke Rehabil       Date:  2006       Impact factor: 2.119

Review 8.  Semantic dementia: a unique clinicopathological syndrome.

Authors:  John R Hodges; Karalyn Patterson
Journal:  Lancet Neurol       Date:  2007-11       Impact factor: 44.182

9.  The logopenic/phonological variant of primary progressive aphasia.

Authors:  M L Gorno-Tempini; S M Brambati; V Ginex; J Ogar; N F Dronkers; A Marcone; D Perani; V Garibotto; S F Cappa; B L Miller
Journal:  Neurology       Date:  2008-07-16       Impact factor: 9.910

10.  Assessing patients' capacities to consent to treatment.

Authors:  P S Appelbaum; T Grisso
Journal:  N Engl J Med       Date:  1988-12-22       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.